Ritter A - Search Results

1

Clinical and biological relevance of glial fibrillary acidic protein in Alzheimer's disease.

Yang Z, Sreenivasan K, Toledano Strom EN, Osse AML, Pasia LG, Cosme CG, Mugosa MRN, Chevalier EL, Ritter A, Miller JB, Cordes D, Cummings JL, Kinney JW. Yang Z, et al. Among authors: ritter a. Alzheimers Res Ther. 2023 Nov 3;15(1):190. doi: 10.1186/s13195-023-01340-4. Alzheimers Res Ther. 2023. PMID: 37924152 Free PMC article.

2

Fluid Biomarkers in Clinical Trials of Alzheimer's Disease Therapeutics.

Ritter A, Cummings J. Ritter A, et al. Front Neurol. 2015 Aug 31;6:186. doi: 10.3389/fneur.2015.00186. eCollection 2015. Front Neurol. 2015. PMID: 26379620 Free PMC article. Review.

3

Neuropsychological Testing in Pathologically Verified Alzheimer Disease and Frontotemporal Dementia: How Well Do the Uniform Data Set Measures Differentiate Between Diseases?

Ritter AR, Leger GC, Miller JB, Banks SJ. Ritter AR, et al. Alzheimer Dis Assoc Disord. 2017 Jul-Sep;31(3):187-191. doi: 10.1097/WAD.0000000000000181. Alzheimer Dis Assoc Disord. 2017. PMID: 28005562 Free PMC article.

4

The Association between Montreal Cognitive Assessment Memory Scores and Hippocampal Volume in a Neurodegenerative Disease Sample.

Ritter A, Hawley N, Banks SJ, Miller JB. Ritter A, et al. J Alzheimers Dis. 2017;58(3):695-699. doi: 10.3233/JAD-161241. J Alzheimers Dis. 2017. PMID: 28453481 Free PMC article.

5

Alzheimer's disease drug development pipeline: 2017.

Cummings J, Lee G, Mortsdorf T, Ritter A, Zhong K. Cummings J, et al. Among authors: ritter a. Alzheimers Dement (N Y). 2017 May 24;3(3):367-384. doi: 10.1016/j.trci.2017.05.002. eCollection 2017 Sep. Alzheimers Dement (N Y). 2017. PMID: 29067343 Free PMC article. Review.

6

Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.

Cummings J, Ritter A, Zhong K. Cummings J, et al. Among authors: ritter a. J Alzheimers Dis. 2018;64(s1):S3-S22. doi: 10.3233/JAD-179901. J Alzheimers Dis. 2018. PMID: 29562511 Free PMC article. Review.

7

Alzheimer's disease drug development pipeline: 2018.

Cummings J, Lee G, Ritter A, Zhong K. Cummings J, et al. Among authors: ritter a. Alzheimers Dement (N Y). 2018 May 3;4:195-214. doi: 10.1016/j.trci.2018.03.009. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 29955663 Free PMC article.

8

Neuroscience learning from longitudinal cohort studies of Alzheimer's disease: Lessons for disease-modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience.

Miller JB, Cummings J, Nance C, Ritter A. Miller JB, et al. Among authors: ritter a. Alzheimers Dement (N Y). 2018 Jul 11;4:350-356. doi: 10.1016/j.trci.2018.06.006. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 30175229 Free PMC article. Review.

9

Statistical advances in clinical trials and clinical research.

Shan G, Banks S, Miller JB, Ritter A, Bernick C, Lombardo J, Cummings JL. Shan G, et al. Among authors: ritter a. Alzheimers Dement (N Y). 2018 Jun 14;4:366-371. doi: 10.1016/j.trci.2018.04.006. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 30175231 Free PMC article.

10

The Pathology of Rapid Cognitive Decline in Clinically Diagnosed Alzheimer's Disease.

Nance C, Ritter A, Miller JB, Lapin B, Banks SJ. Nance C, et al. Among authors: ritter a. J Alzheimers Dis. 2019;70(4):983-993. doi: 10.3233/JAD-190302. J Alzheimers Dis. 2019. PMID: 31306127 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

988 results

Search Page